Characteristics . | Non-GDM (n = 243) . | GDM (n = 243) . | P value . |
---|---|---|---|
At the first antenatal care visit | |||
Gestational age, weeks | 10.1 ± 2.0 | 10.1 ± 2.1 | 0.798a |
Age, year | 29.2 ± 3.3 | 29.2 ± 2.7 | - |
Height, cm | 163.2 ± 4.6 | 163.1 ± 5.0 | 0.950a |
Weight, kg | 58.2 ± 9.6 | 63.7 ± 10.5 | <0.001a |
BMI, kg/m2 | 21.8 ± 3.4 | 23.9 ± 3.6 | <0.001a |
BMI in category | <0.001b | ||
≥24.0 to <28.0 | 45 (18.5) | 77 (31.7) | |
≥28.0 | 12 (4.9) | 31 (12.8) | |
Systolic blood pressure, mmHg | 104.0 ± 10.5 | 108.3 ± 10.5 | <0.001a |
Diastolic blood pressure, mmHg | 67.9 ± 7.7 | 70.6 ± 8.0 | <0.001a |
Han nationality | 234 (96.3) | 238 (98.0) | 0.285b |
Education > 12 year | 132 (54.3) | 135 (55.6) | 0.780b |
Parity ≥ 1 | 12 (4.9) | 14 (5.8) | 0.683b |
Family history of diabetes in first-degree relatives | 14 (5.8) | 30 (12.4) | 0.014b |
Smoking before pregnancy | 9 (3.7) | 10 (4.1) | 0.815b |
Drinking before pregnancy | 57 (23.5) | 72 (29.6) | 0.120b |
Serum BCAA | |||
BCAA, nmol/mL | 341.4 (301.7-390.2) | 368.8 (318.4-418.3) | <0.001a |
Valine, nmol/mL | 174.4 (155.3-200.8) | 187.8 (160.7-218.7) | <0.001a |
Leucine, nmol/mL | 138.4 (122.0-155.3) | 142.7 (128.7-161.1) | 0.016a |
Isoleucine, nmol/mL | 29.5 (24.8-37.4) | 32.1 (26.7-40.8) | 0.004a |
Other serum metabolites | |||
DCA, nmol/mL | 0.26 (0.15-0.45) | 0.20 (0.10-0.32) | 0.002a |
GUDCA, nmol/mL | 0.03 (0.02-0.06) | 0.02 (0.01-0.03) | <0.001a |
SFA16:0, nmol/mL | 14.1 (9.0-24.8) | 19.3 (13.7-30.9) | <0.001a |
LPC18:0, nmol/mL | 13.1 (10.8-17.2) | 22.8 (19.0-28.9) | <0.001a |
At the time of GCT | |||
Smoking during pregnancy | 1 (0.4) | 2 (0.8) | 0.564b |
Smoking either before or during pregnancy | 9 (3.7) | 11 (4.5) | 0.637b |
Drinking during pregnancy | 2 (0.8) | 2 (0.8) | 1.000b |
Drinking either before or during pregnancy | 57 (23.5) | 73 (30.0) | 0.099b |
Weight gain to GCT, kg | 8.7 ± 3.2 | 8.4 ± 3.6 | 0.128a |
Characteristics . | Non-GDM (n = 243) . | GDM (n = 243) . | P value . |
---|---|---|---|
At the first antenatal care visit | |||
Gestational age, weeks | 10.1 ± 2.0 | 10.1 ± 2.1 | 0.798a |
Age, year | 29.2 ± 3.3 | 29.2 ± 2.7 | - |
Height, cm | 163.2 ± 4.6 | 163.1 ± 5.0 | 0.950a |
Weight, kg | 58.2 ± 9.6 | 63.7 ± 10.5 | <0.001a |
BMI, kg/m2 | 21.8 ± 3.4 | 23.9 ± 3.6 | <0.001a |
BMI in category | <0.001b | ||
≥24.0 to <28.0 | 45 (18.5) | 77 (31.7) | |
≥28.0 | 12 (4.9) | 31 (12.8) | |
Systolic blood pressure, mmHg | 104.0 ± 10.5 | 108.3 ± 10.5 | <0.001a |
Diastolic blood pressure, mmHg | 67.9 ± 7.7 | 70.6 ± 8.0 | <0.001a |
Han nationality | 234 (96.3) | 238 (98.0) | 0.285b |
Education > 12 year | 132 (54.3) | 135 (55.6) | 0.780b |
Parity ≥ 1 | 12 (4.9) | 14 (5.8) | 0.683b |
Family history of diabetes in first-degree relatives | 14 (5.8) | 30 (12.4) | 0.014b |
Smoking before pregnancy | 9 (3.7) | 10 (4.1) | 0.815b |
Drinking before pregnancy | 57 (23.5) | 72 (29.6) | 0.120b |
Serum BCAA | |||
BCAA, nmol/mL | 341.4 (301.7-390.2) | 368.8 (318.4-418.3) | <0.001a |
Valine, nmol/mL | 174.4 (155.3-200.8) | 187.8 (160.7-218.7) | <0.001a |
Leucine, nmol/mL | 138.4 (122.0-155.3) | 142.7 (128.7-161.1) | 0.016a |
Isoleucine, nmol/mL | 29.5 (24.8-37.4) | 32.1 (26.7-40.8) | 0.004a |
Other serum metabolites | |||
DCA, nmol/mL | 0.26 (0.15-0.45) | 0.20 (0.10-0.32) | 0.002a |
GUDCA, nmol/mL | 0.03 (0.02-0.06) | 0.02 (0.01-0.03) | <0.001a |
SFA16:0, nmol/mL | 14.1 (9.0-24.8) | 19.3 (13.7-30.9) | <0.001a |
LPC18:0, nmol/mL | 13.1 (10.8-17.2) | 22.8 (19.0-28.9) | <0.001a |
At the time of GCT | |||
Smoking during pregnancy | 1 (0.4) | 2 (0.8) | 0.564b |
Smoking either before or during pregnancy | 9 (3.7) | 11 (4.5) | 0.637b |
Drinking during pregnancy | 2 (0.8) | 2 (0.8) | 1.000b |
Drinking either before or during pregnancy | 57 (23.5) | 73 (30.0) | 0.099b |
Weight gain to GCT, kg | 8.7 ± 3.2 | 8.4 ± 3.6 | 0.128a |
Data are presented as means ± SD, median (interquartile range), or n (%).
Abbreviations: BCAA, branched-chain amino acids; BMI, body mass index; DCA, deoxycholic acid; GCT, glucose challenge test; GDM, gestational diabetes mellitus; GUDCA, glycoursodeoxycholic acid; LPC, lysophosphatidylcholine; SFA, saturated fatty acid.
aDerived from paired t test or Wilcoxon signed-rank test.
bDerived from McNemar test or Fisher’s exact test.
Characteristics . | Non-GDM (n = 243) . | GDM (n = 243) . | P value . |
---|---|---|---|
At the first antenatal care visit | |||
Gestational age, weeks | 10.1 ± 2.0 | 10.1 ± 2.1 | 0.798a |
Age, year | 29.2 ± 3.3 | 29.2 ± 2.7 | - |
Height, cm | 163.2 ± 4.6 | 163.1 ± 5.0 | 0.950a |
Weight, kg | 58.2 ± 9.6 | 63.7 ± 10.5 | <0.001a |
BMI, kg/m2 | 21.8 ± 3.4 | 23.9 ± 3.6 | <0.001a |
BMI in category | <0.001b | ||
≥24.0 to <28.0 | 45 (18.5) | 77 (31.7) | |
≥28.0 | 12 (4.9) | 31 (12.8) | |
Systolic blood pressure, mmHg | 104.0 ± 10.5 | 108.3 ± 10.5 | <0.001a |
Diastolic blood pressure, mmHg | 67.9 ± 7.7 | 70.6 ± 8.0 | <0.001a |
Han nationality | 234 (96.3) | 238 (98.0) | 0.285b |
Education > 12 year | 132 (54.3) | 135 (55.6) | 0.780b |
Parity ≥ 1 | 12 (4.9) | 14 (5.8) | 0.683b |
Family history of diabetes in first-degree relatives | 14 (5.8) | 30 (12.4) | 0.014b |
Smoking before pregnancy | 9 (3.7) | 10 (4.1) | 0.815b |
Drinking before pregnancy | 57 (23.5) | 72 (29.6) | 0.120b |
Serum BCAA | |||
BCAA, nmol/mL | 341.4 (301.7-390.2) | 368.8 (318.4-418.3) | <0.001a |
Valine, nmol/mL | 174.4 (155.3-200.8) | 187.8 (160.7-218.7) | <0.001a |
Leucine, nmol/mL | 138.4 (122.0-155.3) | 142.7 (128.7-161.1) | 0.016a |
Isoleucine, nmol/mL | 29.5 (24.8-37.4) | 32.1 (26.7-40.8) | 0.004a |
Other serum metabolites | |||
DCA, nmol/mL | 0.26 (0.15-0.45) | 0.20 (0.10-0.32) | 0.002a |
GUDCA, nmol/mL | 0.03 (0.02-0.06) | 0.02 (0.01-0.03) | <0.001a |
SFA16:0, nmol/mL | 14.1 (9.0-24.8) | 19.3 (13.7-30.9) | <0.001a |
LPC18:0, nmol/mL | 13.1 (10.8-17.2) | 22.8 (19.0-28.9) | <0.001a |
At the time of GCT | |||
Smoking during pregnancy | 1 (0.4) | 2 (0.8) | 0.564b |
Smoking either before or during pregnancy | 9 (3.7) | 11 (4.5) | 0.637b |
Drinking during pregnancy | 2 (0.8) | 2 (0.8) | 1.000b |
Drinking either before or during pregnancy | 57 (23.5) | 73 (30.0) | 0.099b |
Weight gain to GCT, kg | 8.7 ± 3.2 | 8.4 ± 3.6 | 0.128a |
Characteristics . | Non-GDM (n = 243) . | GDM (n = 243) . | P value . |
---|---|---|---|
At the first antenatal care visit | |||
Gestational age, weeks | 10.1 ± 2.0 | 10.1 ± 2.1 | 0.798a |
Age, year | 29.2 ± 3.3 | 29.2 ± 2.7 | - |
Height, cm | 163.2 ± 4.6 | 163.1 ± 5.0 | 0.950a |
Weight, kg | 58.2 ± 9.6 | 63.7 ± 10.5 | <0.001a |
BMI, kg/m2 | 21.8 ± 3.4 | 23.9 ± 3.6 | <0.001a |
BMI in category | <0.001b | ||
≥24.0 to <28.0 | 45 (18.5) | 77 (31.7) | |
≥28.0 | 12 (4.9) | 31 (12.8) | |
Systolic blood pressure, mmHg | 104.0 ± 10.5 | 108.3 ± 10.5 | <0.001a |
Diastolic blood pressure, mmHg | 67.9 ± 7.7 | 70.6 ± 8.0 | <0.001a |
Han nationality | 234 (96.3) | 238 (98.0) | 0.285b |
Education > 12 year | 132 (54.3) | 135 (55.6) | 0.780b |
Parity ≥ 1 | 12 (4.9) | 14 (5.8) | 0.683b |
Family history of diabetes in first-degree relatives | 14 (5.8) | 30 (12.4) | 0.014b |
Smoking before pregnancy | 9 (3.7) | 10 (4.1) | 0.815b |
Drinking before pregnancy | 57 (23.5) | 72 (29.6) | 0.120b |
Serum BCAA | |||
BCAA, nmol/mL | 341.4 (301.7-390.2) | 368.8 (318.4-418.3) | <0.001a |
Valine, nmol/mL | 174.4 (155.3-200.8) | 187.8 (160.7-218.7) | <0.001a |
Leucine, nmol/mL | 138.4 (122.0-155.3) | 142.7 (128.7-161.1) | 0.016a |
Isoleucine, nmol/mL | 29.5 (24.8-37.4) | 32.1 (26.7-40.8) | 0.004a |
Other serum metabolites | |||
DCA, nmol/mL | 0.26 (0.15-0.45) | 0.20 (0.10-0.32) | 0.002a |
GUDCA, nmol/mL | 0.03 (0.02-0.06) | 0.02 (0.01-0.03) | <0.001a |
SFA16:0, nmol/mL | 14.1 (9.0-24.8) | 19.3 (13.7-30.9) | <0.001a |
LPC18:0, nmol/mL | 13.1 (10.8-17.2) | 22.8 (19.0-28.9) | <0.001a |
At the time of GCT | |||
Smoking during pregnancy | 1 (0.4) | 2 (0.8) | 0.564b |
Smoking either before or during pregnancy | 9 (3.7) | 11 (4.5) | 0.637b |
Drinking during pregnancy | 2 (0.8) | 2 (0.8) | 1.000b |
Drinking either before or during pregnancy | 57 (23.5) | 73 (30.0) | 0.099b |
Weight gain to GCT, kg | 8.7 ± 3.2 | 8.4 ± 3.6 | 0.128a |
Data are presented as means ± SD, median (interquartile range), or n (%).
Abbreviations: BCAA, branched-chain amino acids; BMI, body mass index; DCA, deoxycholic acid; GCT, glucose challenge test; GDM, gestational diabetes mellitus; GUDCA, glycoursodeoxycholic acid; LPC, lysophosphatidylcholine; SFA, saturated fatty acid.
aDerived from paired t test or Wilcoxon signed-rank test.
bDerived from McNemar test or Fisher’s exact test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.